- Q1 2024 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptApr 23, 2024$17.68 (+3.42%)Earnings
- Q4 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptFeb 28, 2024$20.36 (-2.54%)Earnings
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptOct 31, 2023$15.25 (-2.74%)Earnings
- Q2 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptJul 25, 2023$19.48 (+30.39%)Earnings
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Q1 2023 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptMay 02, 2023$12.59 (+14.66%)Earnings
- Q4 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptFeb 28, 2023$12.86 (-3.45%)Earnings
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Kiniksa Pharmaceuticals Ltd at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptNov 01, 2022$12.8 (+12.08%)Earnings
- Q2 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptAug 03, 2022$10.68 (+7.12%)Earnings
- Q1 2022 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptMay 03, 2022$10.11 (+7.44%)Earnings
- Q4 2021 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptFeb 22, 2022$10.62 (-0.93%)Earnings
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptNov 01, 2021$12.73 (+22.52%)Earnings
- Q2 2021 Kiniksa Pharmaceuticals Ltd Earnings Call TranscriptAug 03, 2021$13.69 (-15.65%)Earnings
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Kiniksa Pharmaceuticals Ltd FDA Approval of ARCALYST (rilonacept) for Recurrent Pericarditis Conference Call TranscriptMar 18, 2021
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Kiniksa Pharmaceuticals Ltd Rilonacept Analyst Day TranscriptSep 29, 2020
- Kiniksa Pharmaceuticals Ltd at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Kiniksa Pharmaceuticals Ltd Annual Shareholders Meeting TranscriptJun 30, 2020
- Kiniksa Pharmaceuticals, Ltd. - Special Call TranscriptJun 29, 2020
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Kiniksa Pharmaceuticals Ltd at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Kiniksa Pharmaceuticals Ltd at Barclays Global Healthcare Conference TranscriptMar 12, 2019
Kiniksa Pharmaceuticals Ltd Rilonacept Analyst Day Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Rilonacept Analyst Day conference call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)
I would now like to hand the conference to your speaker today, Mr. Mark Ragosa, Head of Investor Relations. Thank you. Please go ahead.
Good morning, and thank you for joining Kiniksa's webcast covering the burden and unmet need of recurrent pericarditis as well as the potential for rilonacept to treat patients suffering from the disease and our strategy to bring this treatment to patients. The information we present today can be found through the investors and media section of our website.
Turning to the agenda. Our CEO, Sanj Patel, will start with an introduction. We'll also hear a first-hand account of the patient journey and learn more about the burden of recurrent pericarditis, the current treatment paradigm and the unmet need from Dr. Paul Cremer of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)